Roseanne McNamee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Roseanne McNamee has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Raymond Agius
University of Manchester, UK., England, [ protected
3 shared publicationsColin Sibley
University of Manchester, UK., England, [ protected
2 shared publicationsG Burgess
2 shared publications- Kimberly Hannam
Maternal and Fetal Health Research Centre, Institute of Human Development, Medical and Human Sciences, Manchester Academic Health Sciences Centre, University of Manchester and Central Manchester University Hospitals NHS Foundation Trust, Oxford Road, Manchester, M13 9PL, UK
2 shared publications N Cherry
2 shared publications- Philip Newton Baker
College of Life Sciences, University of Leicester, Leicester, United Kingdom
2 shared publications
Latest Publications
- 1 September 2012
- Published by Wolters Kluwer Health in Epidemiology
- Vol. 23
P-039
- 1 September 2012
- Published by Wolters Kluwer Health in Epidemiology
- Vol. 23
O-137
- 20 October 2010
- Published by Wiley in Statistics in Medicine
- Vol. 29 (29) , 2994-3003
Performance of statistical methods for analysing survival data in the presence of non-random compliance
Noncompliance often complicates estimation of treatment efficacy from randomized trials. Under random noncompliance, per protocol analyses or even simple regression adjustments for noncompliance, could be adequate for causal inference, but special methods are needed when noncompliance is related to risk. For survival data, Robins and Tsiatis introduced the semi‐parametric structural Causal Accelerated Life Model (CALM) which allows time‐dependent departures from randomized treatment in either arm and relates each observed event time to a potential event time that would have been observed if the control treatment had been given throughout the trial. Alternatively, Loeys and Goetghebeur developed a structural Proportional Hazards (C‐Prophet) model for when there is all‐or‐nothing noncompliance in the treatment arm only. Whitebiet al. proposed a ‘complier average causal effect’ method for Proportional Hazards estimation which allows time‐dependent departures from randomized treatment in the active arm. A time‐invariant version of this estimator (CHARM) consists of a simple adjustment to the Intention‐to‐Treat hazard ratio estimate. We used simulation studies mimicking a randomized controlled trial of active treatment versus control with censored time‐to‐event data, and under both random and non‐random time‐dependent noncompliance, to evaluate performance of these methods in terms of 95 per cent confidence interval coverage, bias and root mean square errors (RMSE). All methods performed well in terms of bias, even the C‐Prophet used after treating time‐varying compliance as all‐or‐nothing. Coverage of the latter method, as implemented in Stata, was too low. The CALM method performed best in terms of bias and coverage but had the largest RMSE. Copyright © 2010 John Wiley & Sons, Ltd.
- 20 October 2010
- Published by Wiley in Statistics in Medicine
- Vol. 29 (29) , 2994-3003
Performance of statistical methods for analysing survival data in the presence of non-random compliance
Noncompliance often complicates estimation of treatment efficacy from randomized trials. Under random noncompliance, per protocol analyses or even simple regression adjustments for noncompliance, could be adequate for causal inference, but special methods are needed when noncompliance is related to risk. For survival data, Robins and Tsiatis introduced the semi‐parametric structural Causal Accelerated Life Model (CALM) which allows time‐dependent departures from randomized treatment in either arm and relates each observed event time to a potential event time that would have been observed if the control treatment had been given throughout the trial. Alternatively, Loeys and Goetghebeur developed a structural Proportional Hazards (C‐Prophet) model for when there is all‐or‐nothing noncompliance in the treatment arm only. Whitebiet al. proposed a ‘complier average causal effect’ method for Proportional Hazards estimation which allows time‐dependent departures from randomized treatment in the active arm. A time‐invariant version of this estimator (CHARM) consists of a simple adjustment to the Intention‐to‐Treat hazard ratio estimate. We used simulation studies mimicking a randomized controlled trial of active treatment versus control with censored time‐to‐event data, and under both random and non‐random time‐dependent noncompliance, to evaluate performance of these methods in terms of 95 per cent confidence interval coverage, bias and root mean square errors (RMSE). All methods performed well in terms of bias, even the C‐Prophet used after treating time‐varying compliance as all‐or‐nothing. Coverage of the latter method, as implemented in Stata, was too low. The CALM method performed best in terms of bias and coverage but had the largest RMSE. Copyright © 2010 John Wiley & Sons, Ltd.
- 1 May 2010
- Published by Wolters Kluwer Health in Epidemiology
- Vol. 21 (3) , 376-378
Time-sampled Versus Continuous-time Reporting for Measuring Incidence
Accuracy of incidence estimates may be affected by biases that depend on frequency of approach to reporters and reporting window length. A time-sampling strategy enables infrequent approaches with short windows but has never been evaluated. A randomized crossover trial compared incidence estimates of work-related diseases using time-sampled versus continuous-time reporting. Physicians were randomly allocated either to report every month (12/12) in 2004 and for 1 randomly chosen month (1/12) in 2005, or to the reverse sequence. Numbers of new cases of work-related disease reported per reporter per month for 1/12 and 12/12 reporting periods were compared. Response rates were high (87%). Withdrawal from the study was higher under 12/12 reporting. The rate ratio for 1/12 versus 12/12 reporting was 1.26 (95% confidence interval = 1.11-1.42). Rates declined gradually in the 12/12 groups over the year, consistent with reporting fatigue. Increased frequency of data collection may reduce incidence estimates.
- 1 May 2010
- Published by Wolters Kluwer Health in Epidemiology
- Vol. 21 (3) , 376-378
Time-sampled Versus Continuous-time Reporting for Measuring Incidence
Accuracy of incidence estimates may be affected by biases that depend on frequency of approach to reporters and reporting window length. A time-sampling strategy enables infrequent approaches with short windows but has never been evaluated. A randomized crossover trial compared incidence estimates of work-related diseases using time-sampled versus continuous-time reporting. Physicians were randomly allocated either to report every month (12/12) in 2004 and for 1 randomly chosen month (1/12) in 2005, or to the reverse sequence. Numbers of new cases of work-related disease reported per reporter per month for 1/12 and 12/12 reporting periods were compared. Response rates were high (87%). Withdrawal from the study was higher under 12/12 reporting. The rate ratio for 1/12 versus 12/12 reporting was 1.26 (95% confidence interval = 1.11-1.42). Rates declined gradually in the 12/12 groups over the year, consistent with reporting fatigue. Increased frequency of data collection may reduce incidence estimates.
- 3 July 2009
- Published by Wiley in Statistics in Medicine
- Vol. 28 (21) , 2639-2652
Intention to treat, per protocol, as treated and instrumental variable estimators given non‐compliance and effect heterogeneity
We consider the behaviour of three approaches to efficacy estimation—using so‐called ‘as treated’ (AT), ‘per protocol’ (PP) and ‘instrumental variable’ (IV) analyses—and of the Intention to Treat estimator, in a two‐arm randomized treatment trial with a Normally distributed outcome when there is treatment effect heterogeneity and non‐random compliance with assigned treatment. Formulae are derived for the bias of estimators when used either to estimate average treatment effect (ACE) or to estimate complier average treatment effect (CACE) under several models for the relationship between compliance and potential outcomes. These enable the expected values of AT, PP and IV estimators to be ranked in relation to ACE, and show that AT and PP estimators are generally biased for both ACE and CACE even under homogeneity. However, we show that the difference between any pair of (AT, PP, IV) estimates can be used to estimate the correlation between the latent variable determining compliance behaviour and one potential outcome. In the absence of measures that predict compliance, bounds for ACE can only be set given strong assumptions. Regarding the Intention to Treat estimator, while this is ‘biased towards the null’ if viewed as a measure of CACE, we show that it is not always so in relation to ACE. Finally we discuss the behaviour of the estimators under weak and strong null hypotheses. Copyright © 2009 John Wiley & Sons, Ltd.
- 3 July 2009
- Published by Wiley in Statistics in Medicine
- Vol. 28 (21) , 2639-2652
Intention to treat, per protocol, as treated and instrumental variable estimators given non‐compliance and effect heterogeneity
We consider the behaviour of three approaches to efficacy estimation—using so‐called ‘as treated’ (AT), ‘per protocol’ (PP) and ‘instrumental variable’ (IV) analyses—and of the Intention to Treat estimator, in a two‐arm randomized treatment trial with a Normally distributed outcome when there is treatment effect heterogeneity and non‐random compliance with assigned treatment. Formulae are derived for the bias of estimators when used either to estimate average treatment effect (ACE) or to estimate complier average treatment effect (CACE) under several models for the relationship between compliance and potential outcomes. These enable the expected values of AT, PP and IV estimators to be ranked in relation to ACE, and show that AT and PP estimators are generally biased for both ACE and CACE even under homogeneity. However, we show that the difference between any pair of (AT, PP, IV) estimates can be used to estimate the correlation between the latent variable determining compliance behaviour and one potential outcome. In the absence of measures that predict compliance, bounds for ACE can only be set given strong assumptions. Regarding the Intention to Treat estimator, while this is ‘biased towards the null’ if viewed as a measure of CACE, we show that it is not always so in relation to ACE. Finally we discuss the behaviour of the estimators under weak and strong null hypotheses. Copyright © 2009 John Wiley & Sons, Ltd.
- 15 August 2006
- Published by BMJ in Occupational and Environmental Medicine
- Vol. 63 (12) , 813-819
Occupational noise exposure and ischaemic heart disease mortality
Aims:To investigate the hypothesis that long term exposure to excessive noise can increase the risk of ischaemic heart disease.Methods:A case-control design, nested within a cohort of nuclear power workers employed at two sites in England over the period 1950–98, was used. Cases were men who died from ischaemic heart disease (ICD-9: 410–414) aged 75 or under; each was matched to a surviving control of the nearest age who joined the same site at the same time. Personal noise exposure was assessed retrospectively for each man by hygienists using (1) company work histories, (2) noise survey records from 1965–98, and (3) judgements about likely use of hearing protection devices. Men were classified into four groups according to their cumulative exposure to noise, with men whose exposure at the company never exceeded 85dB(A) for at least one year being considered “unexposed”. Risks were compared via odds ratios (ORs) using conditional logistic regression and adjusted for systolic and diastolic blood pressure, height, BMI, and smoking, as measured at recruitment to the company.Results:Analysis was based on 1101 case-control pairs. There was little difference between the exposure groups at recruitment. There was no evidence of increased risk at site A: the ORs for ischaemic heart disease mortality among low, medium, and high exposure categories, compared to unexposed men, being 1.04, 1.00, and 0.77. The corresponding ORs (95% CIs) at site B were 1.15 (0.81–1.65) 1.45 (1.02–2.06), and 1.37 (0.96–1.96). When the comparison was confined to men with at least five years of employment, these dropped to 1.07 (0.64–1.77), 1.33 (0.88–2.01), and 1.21 (0.82–1.79) respectively.Conclusions:The authors did not find statistically robust evidence of increased risk but the estimates at site B are consistent with those in a major cohort study. A strength of the present study is that the validity of noise estimation at site B has been demonstrated elsewhere.
- 15 August 2006
- Published by BMJ in Occupational and Environmental Medicine
- Vol. 63 (12) , 813-819
Occupational noise exposure and ischaemic heart disease mortality
Aims:To investigate the hypothesis that long term exposure to excessive noise can increase the risk of ischaemic heart disease.Methods:A case-control design, nested within a cohort of nuclear power workers employed at two sites in England over the period 1950–98, was used. Cases were men who died from ischaemic heart disease (ICD-9: 410–414) aged 75 or under; each was matched to a surviving control of the nearest age who joined the same site at the same time. Personal noise exposure was assessed retrospectively for each man by hygienists using (1) company work histories, (2) noise survey records from 1965–98, and (3) judgements about likely use of hearing protection devices. Men were classified into four groups according to their cumulative exposure to noise, with men whose exposure at the company never exceeded 85dB(A) for at least one year being considered “unexposed”. Risks were compared via odds ratios (ORs) using conditional logistic regression and adjusted for systolic and diastolic blood pressure, height, BMI, and smoking, as measured at recruitment to the company.Results:Analysis was based on 1101 case-control pairs. There was little difference between the exposure groups at recruitment. There was no evidence of increased risk at site A: the ORs for ischaemic heart disease mortality among low, medium, and high exposure categories, compared to unexposed men, being 1.04, 1.00, and 0.77. The corresponding ORs (95% CIs) at site B were 1.15 (0.81–1.65) 1.45 (1.02–2.06), and 1.37 (0.96–1.96). When the comparison was confined to men with at least five years of employment, these dropped to 1.07 (0.64–1.77), 1.33 (0.88–2.01), and 1.21 (0.82–1.79) respectively.Conclusions:The authors did not find statistically robust evidence of increased risk but the estimates at site B are consistent with those in a major cohort study. A strength of the present study is that the validity of noise estimation at site B has been demonstrated elsewhere.
- 6 June 2006
- Published by BMJ in Occupational and Environmental Medicine
- Vol. 63 (12) , 808-812
Predictive validity of a retrospective measure of noise exposure
To investigate the validity of measures of noise exposure derived retrospectively for a cohort of nuclear energy workers for the period 1950-98, by investigating their ability to predict hearing loss. Subjects were men aged 45-65 chosen from a larger group of employees--assembled for a nested case-control study of noise and death from ischaemic heart disease--who had had at least one audiogram after at least five years' work. Average hearing loss, across both ears and the frequencies 0.5, 1, 2, and 4 kHz, was calculated from the last audiogram for each man. Previous noise exposure at work was assessed retrospectively by three hygienists using work histories, noise survey records from 1965-98, and judgement about use of hearing protection devices. Smoking and age at the time of the audiogram were extracted from records. Differences in hearing loss between men categorised by cumulative noise exposure were assessed after controlling for age, smoking, year of test, and previous test experience. There were 186 and 150 eligible subjects at sites A and B of the company respectively who were employed for an average of 20 years. Compared to men with less than one year's exposure to levels of 85dB(A) or greater, hearing loss was greater by 3.7 dB (90% CI -2.6 to 10.1), 3.8 dB (90% CI -2.6 to 10.3), 7.0 dB (90% CI 1.1 to 12.9) and 10.1 dB (90% CI 4.2 to 16.0) in the lowest to highest categories of cumulative noise exposure at site B. In contrast, at site A, the corresponding figures were -2.2 dB, -2.4 dB, -1.8 dB, and -4.4 dB, with no confidence interval excluding zero. Noise estimation at one site was shown to have predictive validity in terms of hearing loss, but not at the other site. Reasons for the differences between sites are discussed.
- 6 June 2006
- Published by BMJ in Occupational and Environmental Medicine
- Vol. 63 (12) , 808-812
Predictive validity of a retrospective measure of noise exposure
To investigate the validity of measures of noise exposure derived retrospectively for a cohort of nuclear energy workers for the period 1950-98, by investigating their ability to predict hearing loss. Subjects were men aged 45-65 chosen from a larger group of employees--assembled for a nested case-control study of noise and death from ischaemic heart disease--who had had at least one audiogram after at least five years' work. Average hearing loss, across both ears and the frequencies 0.5, 1, 2, and 4 kHz, was calculated from the last audiogram for each man. Previous noise exposure at work was assessed retrospectively by three hygienists using work histories, noise survey records from 1965-98, and judgement about use of hearing protection devices. Smoking and age at the time of the audiogram were extracted from records. Differences in hearing loss between men categorised by cumulative noise exposure were assessed after controlling for age, smoking, year of test, and previous test experience. There were 186 and 150 eligible subjects at sites A and B of the company respectively who were employed for an average of 20 years. Compared to men with less than one year's exposure to levels of 85dB(A) or greater, hearing loss was greater by 3.7 dB (90% CI -2.6 to 10.1), 3.8 dB (90% CI -2.6 to 10.3), 7.0 dB (90% CI 1.1 to 12.9) and 10.1 dB (90% CI 4.2 to 16.0) in the lowest to highest categories of cumulative noise exposure at site B. In contrast, at site A, the corresponding figures were -2.2 dB, -2.4 dB, -1.8 dB, and -4.4 dB, with no confidence interval excluding zero. Noise estimation at one site was shown to have predictive validity in terms of hearing loss, but not at the other site. Reasons for the differences between sites are discussed.
- Open Access
- 28 April 2005
- Published by Oxford University Press (OUP) in Biostatistics
- Vol. 6 (4) , 590-603
Optimal design and efficiency of two-phase case–control studies with error-prone and error-free exposure measures
This paper addresses optimal design and efficiency of two-phase (2P) case–control studies in which the first phase uses an error-prone exposure measure, Z, while the second phase measures true, dichotomous exposure, X, in a subset of subjects. Optimal design of a separate second phase, to be added to a preexisting study, is also investigated. Differential misclassification is assumed throughout. Results are also applicable to 2P cohort studies with error-prone and error-free measures of disease status but error-free exposure measures. While software based on the mean score method of Reilly and Pepe (1995, Biometrika82, 299–314) can find optimal designs given pilot data, the lack of simple formulae makes it difficult to generalize about efficiency compared to one-phase (1P) studies based on X alone. Here, formulae for the optimal ratios of cases to controls and first- to second-phase sizes, and the optimal second-phase stratified sampling fractions, given a fixed budget, are given. The maximum efficiency of 2P designs compared to a 1P design is deduced and is shown to be bounded from above by a function of the sensitivities and specificities of Z. The efficiency of ‘balanced’ separate second-phase designs (Breslow and Cain, 1988, Biometrika75, 11–20)—in which equal numbers of subjects are chosen from each first-phase strata—compared to optimal design is deduced, enabling situations where balanced designs are nearly optimal to be identified.
- 28 April 2005
- Published by Oxford University Press (OUP) in Biostatistics
- Vol. 6 (4) , 590-603
Open AccessOptimal design and efficiency of two-phase case–control studies with error-prone and error-free exposure measures
This paper addresses optimal design and efficiency of two-phase (2P) case–control studies in which the first phase uses an error-prone exposure measure, Z, while the second phase measures true, dichotomous exposure, X, in a subset of subjects. Optimal design of a separate second phase, to be added to a preexisting study, is also investigated. Differential misclassification is assumed throughout. Results are also applicable to 2P cohort studies with error-prone and error-free measures of disease status but error-free exposure measures. While software based on the mean score method of Reilly and Pepe (1995, Biometrika82, 299–314) can find optimal designs given pilot data, the lack of simple formulae makes it difficult to generalize about efficiency compared to one-phase (1P) studies based on X alone. Here, formulae for the optimal ratios of cases to controls and first- to second-phase sizes, and the optimal second-phase stratified sampling fractions, given a fixed budget, are given. The maximum efficiency of 2P designs compared to a 1P design is deduced and is shown to be bounded from above by a function of the sensitivities and specificities of Z. The efficiency of ‘balanced’ separate second-phase designs (Breslow and Cain, 1988, Biometrika75, 11–20)—in which equal numbers of subjects are chosen from each first-phase strata—compared to optimal design is deduced, enabling situations where balanced designs are nearly optimal to be identified.